Oxytocin
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SYNTOCINON | — | 1980-04-17 | fda.gov ↗ |
Trials 396 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 033 trials | ||||||
| Phase 0 | NCT07140237 | Sep → Dec 2025 overdue | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| Phase 0 | NCT07093060 | Jun → Nov 2025 overdue | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| Phase 0 | NCT03414112 | Sep 2018 → Apr 2021 | anorexia nervosa | University of Minnesota | Completed | No outcome recorded |
| Phase 0 | NCT03136263 | Dec 2017 → Nov 2020 | attention deficit-hyperactivity disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 0 | NCT03211013 | Jul 2017 → Jun 2021 | post-traumatic stress disorder | Palo Alto Veterans Institute for Research | Completed | No outcome recorded |
| Phase 0 | NCT03085654 | Mar 2017 → Mar 2018 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 0 | NCT03144115 | Oct 2016 → Jun 2018 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 0 | NCT02741063 | May 2016 → Jun 2019 | — | University of Electronic Science and Technology of China | Unknown | No outcome recorded |
| Phase 0 | NCT03055546 | Feb 2016 → Dec 2018 | — | University of Electronic Science and Technology of China | Unknown | No outcome recorded |
| Phase 0 | NCT02469259 | Feb 2016 → Feb 2018 | alcohol dependence, post-traumatic stress disorder | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT02361177 | Jan → Apr 2016 | disruptive behavior disorder | University of Texas at Austin | Withdrawn | No outcome recorded |
| Phase 0 | NCT03084029 | Jan 2016 → Jun 2017 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 0 | NCT02396303 | Jun → Oct 2015 | — | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
| Phase 0 | NCT02564068 | May 2015 → Dec 2016 | obstructive sleep apnea syndrome | George Washington University | Completed | No outcome recorded |
| Phase 0 | NCT02443727 | Apr → Dec 2015 | — | Rodrigo Cardenas | Completed | No outcome recorded |
| Phase 0 | NCT02221830 | Feb 2015 → Jul 2019 | preeclampsia | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 0 | NCT02393443 | Jan 2015 → Jul 2016 | — | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 0 | NCT02393456 | Jan 2015 → Jul 2016 | — | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 0 | NCT02740101 | Nov 2014 → Aug 2015 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 0 | NCT02228031 | Oct 2014 → Aug 2016 | CGF1 | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 0 | NCT02276677 | Oct 2014 → May 2015 | morbid obesity | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 0 | NCT02238379 | Sep 2014 → Dec 2015 | — | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT02501837 | Jul 2014 → Jun 2015 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 0 | NCT02183948 | Jun → Dec 2014 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 0 | NCT02091817 | Nov 2013 → Dec 2016 | prosopagnosia | Soroka University Medical Center | Suspended | No outcome recorded |
| Phase 0 | NCT01680718 | Oct 2012 → Sep 2013 | — | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 0 | NCT02566356 | Sep 2012 → Sep 2017 | schizophrenia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT01701180 | Aug 2012 → Aug 2013 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 0 | NCT01728909 | May 2012 → Oct 2014 | opiate dependence, substance abuse | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT02567032 | Oct 2010 → Aug 2019 | CGF1, schizophrenia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT02577575 | Aug 2010 → Nov 2015 | schizophrenia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT00914953 | Feb → Dec 2010 | — | Claremont Graduate University | Completed | No outcome recorded |
| Phase 0 | NCT00776360 | Dec 2008 → Dec 2009 | functional gastric disease | Skane University Hospital | Completed | No outcome recorded |
| Phase 140 trials | ||||||
| Phase 1 | NCT06332066 | May 2024 | — | Shalvata Mental Health Center | Unknown | No outcome recorded |
| Phase 1 | NCT05865288 | Jun 2023 → Apr 2024 | eating disorder | Shalvata Mental Health Center | Unknown | No outcome recorded |
| Phase 1 | NCT05672667 | Feb → Nov 2023 | — | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 1 | NCT04051619 | Jan 2020 → Dec 2023 | substance-related disorder | Brown University | Completed | No outcome recorded |
| Phase 1 | NCT04292444 | Dec 2019 → May 2021 | — | University Hospital, Bonn | Unknown | No outcome recorded |
| Phase 1 | NCT04137432 | Sep 2019 → Sep 2020 | — | University Hospital, Bonn | Unknown | No outcome recorded |
| Phase 1 | NCT03860233 | Mar 2019 → Dec 2026 expected | obstructive sleep apnea syndrome | Vivek Jain | Recruiting | No outcome recorded |
| Phase 1 | NCT02908126 | Apr 2018 → Jun 2019 | — | Oxytone Bioscience BV | Terminated | No outcome recorded |
| Phase 1 | NCT03610919 | Mar → Sep 2018 | — | University of Electronic Science and Technology of China | Unknown | No outcome recorded |
| Phase 1 | NCT03255148 | Jul 2017 → May 2018 | — | KU Leuven | Completed | No outcome recorded |
| Phase 1 | NCT03060031 | Jun 2017 → Mar 2019 | — | University of Colorado, Boulder | Completed | No outcome recorded |
| Phase 1 | NCT02881177 | Jan 2017 → Jul 2018 | amphetamine abuse | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT02999100 | Nov 2016 → Mar 2019 | — | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 1 | NCT04330677 | Sep 2016 → Jan 2020 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT03183674 | Jul 2016 → Jul 2017 | autism spectrum disorder | University of Sao Paulo General Hospital | Completed | No outcome recorded |
| Phase 1 | NCT02872467 | May 2016 → Mar 2023 | pregnancy disorder, substance abuse | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT02911480 | Apr 2016 → Feb 2017 | — | Oxytone Bioscience BV | Withdrawn | No outcome recorded |
| Phase 1 | NCT02069431 | Feb 2016 → May 2020 | — | University of Florida | Terminated | No outcome recorded |
| Phase 1 | NCT02745522 | Dec 2015 → Mar 2017 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| Phase 1 | NCT02302430 | Oct 2015 → May 2018 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT02542813 | Sep → Dec 2015 | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT03265899 | Jul 2015 → Nov 2016 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02098421 | Nov 2014 → Apr 2016 | — | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
| Phase 1 | NCT01945957 | Sep 2014 → Jan 2017 | autism spectrum disorder | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT02213029 | Aug 2014 → Feb 2016 | — | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 1 | NCT02058251 | Feb 2014 → Jan 2017 | alcohol-related disorders | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 1 | NCT01983514 | Oct 2013 → Feb 2014 | — | OptiNose AS | Completed | No outcome recorded |
| Phase 1 | NCT01929161 | Sep 2013 → Sep 2014 | — | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT01912378 | Aug 2013 → May 2015 | autism spectrum disorder | University of California, San Francisco | Withdrawn | No outcome recorded |
| Phase 1 | NCT01939639 | Mar → Jun 2013 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02052258 | Jan 2013 → Dec 2015 | opiate dependence | MacDonald, Kai, M.D. | Unknown | No outcome recorded |
| Phase 1 | NCT01517360 | Jan 2012 → Feb 2013 | schizophrenia | VA Greater Los Angeles Healthcare System | Completed | No outcome recorded |
| Phase 1 | NCT01607970 | Aug 2011 → May 2012 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT01394471 | Jul 2011 → Jan 2015 | schizoaffective disorder, schizophrenia | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT01386333 | Jun 2011 → Oct 2013 | frontotemporal dementia | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 1 | NCT01606462 | Jun 2011 → Jun 2013 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02302209 | Apr 2011 → Oct 2017 | autism spectrum disorder, schizophrenia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT01212185 | Jul 2010 → Mar 2011 | alcohol withdrawal | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT01093768 | Feb 2010 → Apr 2013 | autism spectrum disorder | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
| Phase 1 | NCT00263796 | Mar 2006 → Oct 2010 | autism | Anagnostou, Evdokia, M.D. | Completed | No outcome recorded |
| Phase 1/29 trials | ||||||
| Phase 1/2 | NCT05405257 | May 2022 → Mar 2025 | Ehlers-Danlos syndrome, hypermobility type | Baylor College of Medicine | Terminated | No outcome recorded |
| Phase 1/2 | NCT04306354 | Sep 2018 → Apr 2020 | cocaine abuse, cocaine dependence, substance withdrawal syndrome | Pontifical Catholic University of Rio Grande do Sul | Unknown | No outcome recorded |
| Phase 1/2 | NCT03119610 | Sep 2017 → Dec 2018 | muscular atrophy, obesity disorder | Sara Espinoza | Completed | No outcome recorded |
| Phase 1/2 | NCT03272321 | Jul 2017 → May 2018 | — | KU Leuven | Completed | No outcome recorded |
| Phase 1/2 | NCT03096249 | Nov 2016 → May 2017 | — | KU Leuven | Completed | No outcome recorded |
| Phase 1/2 | NCT02548728 | Feb → Dec 2016 | opiate dependence, substance withdrawal syndrome | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1/2 | NCT01712646 | Oct 2012 → Jun 2016 | childhood-onset schizophrenia | National Institute of Mental Health (NIMH) | Terminated | No outcome recorded |
| Phase 1/2 | NCT01856530 | Jul 2012 → Aug 2013 | social phobia | Stefan G. Hofmann | Completed | No outcome recorded |
| Phase 1/2 | NCT01548521 | Jul 2011 → Feb 2012 | Prader-Willi syndrome | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 2111 trials | ||||||
| Phase 2 | NCT07430228 | Jul 2026 → Dec 2027 expected | — | Wake Forest University Health Sciences | Enrolling by invitation | No outcome recorded |
| Phase 2 | NCT06968481 | May → Oct 2026 expected | — | Insud Pharma | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07053774 | Nov 2025 → Jun 2026 | — | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 2 | NCT07409753 | Oct 2025 → Jun 2027 expected | — | Wake Forest University Health Sciences | Recruiting | No outcome recorded |
| Phase 2 | NCT06808516 | Jul 2025 → Dec 2026 expected | neurohypophyseal diabetes insipidus | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 2 | NCT06945926 | Jun 2025 → Jun 2026 overdue | avascular necrosis, lumbar spinal stenosis, rotator cuff syndrome, spinal cord injury | Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06676774 | May 2025 → Feb 2027 expected | neurohypophyseal diabetes insipidus | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 2 | NCT05488457 | Jan 2025 → Dec 2026 expected | — | University of Chicago | Recruiting | No outcome recorded |
| Phase 2 | NCT04435704 | Jan 2025 → Jan 2027 | osteoarthritis, knee | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2 | NCT04433741 | Jan → Dec 2025 | chronic pain syndrome | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Show all 111 trials opens the full record — a long page | ||||||
| Phase 2/310 trials | ||||||
| Phase 2/3 | NCT06248710 | Jan → Dec 2024 overdue | depressive disorder, zoophilia | Dr. Karin Hediger | Recruiting | No outcome recorded |
| Phase 2/3 | NCT05627791 | Nov 2022 → Jul 2023 | postmenopausal atrophic vaginitis | Department of Medical Services Ministry of Public Health of Thailand | Terminated | No outcome recorded |
| Phase 2/3 | NCT05298085 | Apr 2022 → Apr 2023 | Prader-Willi syndrome | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 2/3 | NCT04903002 | Apr 2022 → Mar 2026 overdue | chronic pain syndrome | Memorial University of Newfoundland | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT05093296 | Dec 2021 → Jul 2023 | alcohol dependence | Central Institute of Mental Health, Mannheim | Completed | No outcome recorded |
| Phase 2/3 | NCT02409862 | Jan → Aug 2019 | — | University of Florida | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03819231 | Oct 2018 → Dec 2023 | — | University of Southern California | Terminated | No outcome recorded |
| Phase 2/3 | NCT03001635 | Jan 2017 → Dec 2018 | myocardial infarction | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 2/3 | NCT02888574 | Nov 2016 → Dec 2018 | chronic pain syndrome, pelvis syndrome | University of Calgary | Completed | No outcome recorded |
| Phase 2/3 | NCT02508103 | Jul 2015 → Jun 2016 | premenstrual dysphoric disorder | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 318 trials | ||||||
| Phase 3 | NCT06010368 | Oct 2024 → Dec 2025 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06725004 | Jan → Dec 2023 | female infertility, polycystic ovary syndrome | Shakeela Ishrat | Completed | No outcome recorded |
| Phase 3 | NCT04949633 | Sep 2021 → Sep 2026 expected | cervix disorder | University Hospital, Tours | Recruiting | No outcome recorded |
| Phase 3 | NCT04210310 | Jan 2020 → May 2022 | tinnitus | NYU Langone Health | Terminated | No outcome recorded |
| Phase 3 | NCT03640156 | Jul 2018 → Dec 2019 | autism spectrum disorder | KU Leuven | Completed | No outcome recorded |
| Phase 3 | NCT03339024 | Nov 2017 → Mar 2019 | alcohol dependence | Norwegian University of Science and Technology | Completed | No outcome recorded |
| Phase 3 | NCT02985749 | Oct 2017 → Jan 2019 | autism spectrum disorder 1 | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02903251 | Oct 2016 → Jan 2018 | alcohol dependence | Norwegian University of Science and Technology | Completed | No outcome recorded |
| Phase 3 | NCT02794779 | Jul 2016 → Dec 2017 | — | Brasilia University Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02618499 | May → Nov 2016 | — | Fundacion para la Salud Materno Infantil | Terminated | No outcome recorded |
| Phase 3 | NCT02720978 | May 2016 → May 2019 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02684305 | Apr 2016 → Apr 2018 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02319707 | Sep 2015 → Jan 2017 | — | Yariv yogev | Unknown | No outcome recorded |
| Phase 3 | NCT01932060 | Aug 2013 → Sep 2015 | — | Stanford University | Completed | No outcome recorded |
| Phase 3 | NCT01710566 | Jul 2013 → Dec 2014 | — | Gynuity Health Projects | Withdrawn | No outcome recorded |
| Phase 3 | NCT01767025 | Nov → Dec 2012 | — | University Ghent | Completed | No outcome recorded |
| Phase 3 | NCT01397630 | Apr 2012 → Oct 2013 | dystocia | Ottawa Hospital Research Institute | Terminated | No outcome recorded |
| Phase 3 | NCT01094028 | Dec 2009 → Mar 2010 | — | Erzincan Military Hospital | Completed | No outcome recorded |
| Phase 438 trials | ||||||
| Phase 4 | NCT07636421 | Aug 2026 → Apr 2028 expected | uterine disorder | Mansoura University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07566455 | Aug 2025 → Feb 2026 | — | CMH Multan Institute of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT06990217 | Jun 2025 → Jun 2027 expected | — | HaEmek Medical Center, Israel | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05823441 | Jun 2023 → Jan 2024 | — | Peking University People's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05608070 | Jun 2023 → Jun 2024 | — | Beth Israel Deaconess Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT05568745 | Jan 2023 → Feb 2025 | cervix disorder, preterm premature rupture of the membranes | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 4 | NCT05289869 | Apr → Sep 2022 | — | Ohio State University | Completed | No outcome recorded |
| Phase 4 | NCT04760496 | Oct 2021 → Dec 2024 | obesity disorder | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 4 | NCT03991091 | Jan 2020 → Apr 2022 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 4 | NCT03749902 | Jan 2020 → Jul 2022 | — | University of Liverpool | Completed | No outcome recorded |
| Phase 4 | NCT04105998 | Oct 2019 → Nov 2021 | chronic pain syndrome | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03935399 | Aug 2019 → Mar 2020 | chronic pain syndrome | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03929367 | May 2019 → Mar 2020 | chronic pain syndrome | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03361124 | Mar 2019 → Mar 2020 | anemia, uterine disorder | Milton S. Hershey Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT03232918 | Feb 2019 → Dec 2025 overdue | cardiac rhythm disease | Unyime Ituk | Recruiting | No outcome recorded |
| Phase 4 | NCT03937401 | Feb → Dec 2019 | adenomyosis, leiomyoma | Turku University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03604874 | Sep 2018 → Aug 2020 | dystocia | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT03245437 | Jan 2018 → Jul 2024 | schizophrenia | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 4 | NCT03308643 | Oct 2017 → May 2018 | uterine corpus leiomyoma | Kanuni Sultan Suleyman Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03140488 | Jun 2017 → Oct 2018 | obesity disorder | University of Arizona | Completed | No outcome recorded |
| Phase 4 | NCT02969447 | Oct 2016 → Aug 2017 | placenta disorder | University Hospital, Bordeaux | Completed | No outcome recorded |
| Phase 4 | NCT03344302 | Oct 2016 → Aug 2017 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT02801227 | Sep 2016 → Sep 2017 | preterm premature rupture of the membranes | Shaare Zedek Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02595749 | Jul 2016 → Jul 2019 | nicotine dependence | University of Southern California | Completed | No outcome recorded |
| Phase 4 | NCT02737254 | Mar → Oct 2016 | — | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT03010670 | Jan → Aug 2016 | — | KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT02487797 | Sep 2015 → Sep 2020 | dystocia | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT02940574 | Apr 2015 → Dec 2016 | autism spectrum disorder | KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT02336568 | Mar 2015 → Dec 2016 | post-traumatic stress disorder | Rambam Health Care Campus | Unknown | No outcome recorded |
| Phase 4 | NCT01829516 | May 2013 → May 2014 | substance-related disorder | University of California, San Francisco | Completed | No outcome recorded |
| Phase 4 | NCT01827124 | Apr → Nov 2013 | — | Wafaa Uthman Ahmed | Unknown | No outcome recorded |
| Phase 4 | NCT01325168 | Aug 2011 → Aug 2012 | post-traumatic stress disorder | Rambam Health Care Campus | Completed | No outcome recorded |
| Phase 4 | NCT01252342 | Aug 2011 → Apr 2012 | uterine disorder | University of Saskatchewan | Withdrawn | No outcome recorded |
| Phase 4 | NCT01631682 | Nov 2010 → Jan 2015 | post-traumatic stress disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01236482 | Nov 2010 → May 2011 | — | Hadassah Medical Organization | Unknown | No outcome recorded |
| Phase 4 | NCT01081249 | Dec 2008 → Jul 2012 | anxiety | MacDonald, Kai, M.D. | Completed | No outcome recorded |
| Phase 4 | NCT00790062 | Nov 2008 → Jun 2010 | uterine disorder | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 4 | NCT00785395 | Jun → Aug 2008 | uterine disorder | IWK Health Centre | Completed | No outcome recorded |
| Phase not applicable137 trials | ||||||
| — | NCT07687355 | Jul → Oct 2026 expected | — | Hayatabad Medical Complex | Not yet recruiting | No outcome recorded |
| — | NCT07559656 | Apr → Sep 2026 expected | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| — | NCT07366359 | Feb 2026 → Dec 2027 expected | cervix disorder, preterm premature rupture of the membranes | National Hospital of Obstetrics and Gynecology | Recruiting | No outcome recorded |
| — | NCT07425938 | Jan → Apr 2026 overdue | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| — | NCT07318467 | Jan → Jun 2026 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT07162584 | Sep 2025 → Jan 2026 overdue | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| — | NCT07006896 | Jul 2025 → Jul 2026 overdue | — | University of Pennsylvania | Active not recruiting | No outcome recorded |
| — | NCT06881459 | Mar → Jul 2025 | type 1 diabetes mellitus | University Hospital, Gentofte, Copenhagen | Completed | No outcome recorded |
| — | NCT06605300 | Oct 2024 → Jul 2025 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| — | NCT07053930 | Oct 2024 → Mar 2025 | — | RESnTEC, Institute of Research | Completed | No outcome recorded |
| Show all 137 trials opens the full record — a long page | ||||||
Also used as a comparator or background therapy in 224 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 08 trials | ||||||
| Phase 0 | NCT05761860 Comparator | Sep 2023 → Dec 2026 expected | — | University of Florida | Recruiting | No outcome recorded |
| Phase 0 | NCT04218409 Comparator | Sep 2021 → Dec 2026 expected | — | University of Florida | Recruiting | No outcome recorded |
| Phase 0 | NCT04478942 Comparator | Oct 2020 → Jan 2025 | preterm premature rupture of the membranes | University of Wisconsin, Madison | Completed | No outcome recorded |
| Phase 0 | NCT04549012 Comparator | Sep 2020 → Sep 2021 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 0 | NCT04089176 Comparator | Feb → Apr 2019 | — | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| Phase 0 | NCT01780337 Comparator | Jan 2013 → May 2016 | cardiac rhythm disease | William Whang | Completed | No outcome recorded |
| Phase 0 | NCT02568709 Comparator | Feb 2012 → Dec 2016 | schizophrenia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT01513499 Comparator | Jan 2012 → Jan 2014 | eating disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 122 trials | ||||||
| Phase 1 | NCT04789148 Comparator | Sep 2025 → Jun 2026 overdue | neurohypophyseal diabetes insipidus | Elizabeth Austen Lawson | Recruiting | No outcome recorded |
| Phase 1 | NCT04071119 Comparator | Nov 2020 → Apr 2024 | alcohol-related disorders | Brown University | Completed | No outcome recorded |
| Phase 1 | NCT04007224 Comparator | Jan 2019 → Jun 2023 | autism spectrum disorder | Fundatia Bio-Forum | Completed | No outcome recorded |
| Phase 1 | NCT03337035 Comparator | Dec 2018 → Oct 2019 | autism spectrum disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 1 | NCT03390010 Comparator | Dec 2017 → Feb 2018 | — | Aljazeera Hospital | Completed | No outcome recorded |
| Phase 1 | NCT03543917 Background | Aug 2017 → Aug 2018 | stroke disorder | Fundatia Bio-Forum | Completed | No outcome recorded |
| Phase 1 | NCT03846739 Comparator | Apr 2017 → Dec 2018 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT03425929 Comparator | Jun 2016 → Mar 2017 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02711189 Comparator | Mar 2016 → Feb 2019 | alcohol dependence | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Withdrawn | No outcome recorded |
| Phase 1 | NCT03829839 Comparator | Mar 2016 → Aug 2017 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02013258 Comparator | Mar → Aug 2015 | Prader-Willi syndrome | University of Florida | Completed | No outcome recorded |
| Phase 1 | NCT02407340 Comparator | Mar 2015 → Jun 2017 | alcohol dependence | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT02680938 Comparator | Jan 2015 → Feb 2016 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 1 | NCT03011970 Comparator | Sep 2014 → Dec 2015 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT02028533 Comparator | Jul → Dec 2014 | substance-related disorder | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT02301715 Comparator | Apr 2014 → May 2017 | — | Centre Hospitalier Universitaire de Besancon | Completed | No outcome recorded |
| Phase 1 | NCT02149823 Comparator | Sep 2013 → Jul 2020 | autism spectrum disorder, bipolar disorder, borderline personality disorder, schizoaffective disorder +2 | Maria de las Mercedes Perez Rodriguez | Terminated | No outcome recorded |
| Phase 1 | NCT02156661 Comparator | May 2013 → Jun 2014 | — | University Hospital, Bonn | Completed | No outcome recorded |
| Phase 1 | NCT01863706 Comparator | May → Dec 2013 | — | Hormozgan University of Medical Sciences | Completed | No outcome recorded |
| Phase 1 | NCT01834261 Comparator | Apr 2013 → May 2015 | — | Stony Brook University | Completed | No outcome recorded |
| Phase 1 | NCT01239888 Comparator | Jan → Nov 2012 | major depressive disorder | The Alfred | Unknown | No outcome recorded |
| Phase 1 | NCT01594775 Comparator | Oct 2011 → Oct 2013 | — | University of Zurich | Completed | No outcome recorded |
| Phase 1/28 trials | ||||||
| Phase 1/2 | NCT05510310 Comparator | Oct 2022 → Oct 2024 | uterine disorder | Western Galilee Hospital-Nahariya | Unknown | No outcome recorded |
| Phase 1/2 | NCT03863288 Comparator | Feb 2022 → Feb 2024 | mood disorder | University of Nebraska | Terminated | No outcome recorded |
| Phase 1/2 | NCT04656067 Comparator | Apr → Oct 2020 | — | Egymedicalpedia | Completed | No outcome recorded |
| Phase 1/2 | NCT04707950 Comparator | Jan 2020 → Feb 2021 | — | Benha University | Unknown | No outcome recorded |
| Phase 1/2 | NCT03245762 Comparator | Aug 2017 → Jan 2018 | Prader-Willi syndrome | University of Florida | Completed | No outcome recorded |
| Phase 1/2 | NCT02414503 Comparator | Apr 2015 → Feb 2016 | autism spectrum disorder | OptiNose AS | Completed | No outcome recorded |
| Phase 1/2 | NCT02205034 Comparator | May 2013 → Jul 2014 | Prader-Willi syndrome | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 1/2 | NCT01571323 Comparator | Feb → Aug 2012 | — | Qazvin University Of Medical Sciences | Completed | No outcome recorded |
| Phase 223 trials | ||||||
| Phase 2 | NCT06364228 Comparator | Jun 2026 → May 2027 expected | — | University of Nebraska | Recruiting | No outcome recorded |
| Phase 2 | NCT06483659 Comparator | Jun 2025 → Jul 2026 overdue | — | Brigham and Women's Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT06036004 Comparator | Jan 2024 → Oct 2026 expected | central diabetes insipidus | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 2 | NCT03878316 Comparator | Jun 2022 → Oct 2023 | alcohol abuse | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | No outcome recorded |
| Phase 2 | NCT04117243 Comparator | Jan → Dec 2020 | — | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT03636555 Comparator | Oct 2019 → Sep 2022 | alcohol-related disorders | University of North Carolina, Chapel Hill | Withdrawn | No outcome recorded |
| Phase 2 | NCT03742531 Comparator | Dec 2018 → Jun 2019 | — | Zeynep Kamil Maternity and Pediatric Research and Training Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02441673 Comparator | Oct 2018 → Jan 2019 | benign shuddering attacks | Lagos State Health Service Commission | Unknown | No outcome recorded |
| Phase 2 | NCT03001193 Background | Dec 2016 → Nov 2018 | dystocia | Dilafor AB | Completed | No outcome recorded |
| Phase 2 | NCT02505984 Comparator | Jan 2016 → May 2023 | anxiety, postpartum depression | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01944046 Comparator | Aug 2014 → Nov 2017 | autism spectrum disorder | Linmarie Sikich | Completed | No outcome recorded |
| Phase 2 | NCT01788072 Comparator | Jun 2014 → Aug 2017 | autism spectrum disorder | Holland Bloorview Kids Rehabilitation Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02318121 Comparator | Apr → Sep 2014 | dystocia | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02090829 Comparator | Mar 2014 → Mar 2018 | autism spectrum disorder | University of Minnesota | Withdrawn | No outcome recorded |
| Phase 2 | NCT02562300 Comparator | Jan 2014 → Jan 2015 | — | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02275611 Comparator | Jan → Dec 2013 | alcohol dependence, alcohol withdrawal | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 2 | NCT02229721 Comparator | Jun 2012 → Oct 2013 | sexual disorder | Medical University of Vienna | Completed | No outcome recorded |
| Phase 2 | NCT01624194 Comparator | Jun 2012 → May 2016 | autism | Stanford University | Completed | No outcome recorded |
| Phase 2 | NCT01417026 Comparator | Sep 2011 → Apr 2015 | autism spectrum disorder | Robert Schultz | Completed | No outcome recorded |
| Phase 2 | NCT01308749 Comparator | Mar 2011 → Apr 2013 | autism | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 2 | NCT00890630 Background | Apr 2010 → Jul 2011 | preterm premature rupture of the membranes | McMaster University | Terminated | No outcome recorded |
| Phase 2 | NCT01012167 Comparator | Feb 2010 → Jul 2014 | schizophrenia | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 2 | NCT00844350 Comparator | Oct 2006 → Sep 2007 | ovarian disorder | Tabriz University | Completed | No outcome recorded |
| Phase 2/36 trials | ||||||
| Phase 2/3 | NCT06702670 Background | Mar 2025 → Mar 2027 expected | dystocia | The University of Texas Health Science Center, Houston | Recruiting | No outcome recorded |
| Phase 2/3 | NCT03878589 Comparator | Aug 2019 → Dec 2024 | osteoarthritis, knee | University of Florida | Completed | No outcome recorded |
| Phase 2/3 | NCT02786992 Comparator | May 2016 → Jan 2020 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT02007447 Comparator | Jun → Aug 2015 | autism spectrum disorder | University of Sao Paulo General Hospital | Terminated | No outcome recorded |
| Phase 2/3 | NCT02255357 Comparator | Mar 2015 → Feb 2018 | cocaine dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2/3 | NCT02804373 Comparator | Jun 2014 → Jan 2019 | Prader-Willi syndrome | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 321 trials | ||||||
| Phase 3 | NCT05245227 Background | Jan 2025 → Jan 2027 expected | — | Stony Brook University | Recruiting | No outcome recorded |
| Phase 3 | NCT06514586 Comparator | Sep 2024 → Jun 2025 overdue | postmenopausal atrophic vaginitis, skin atrophy | Oxagon | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06259097 Comparator | Jul 2024 → Jul 2026 overdue | pregnancy disorder | Icahn School of Medicine at Mount Sinai | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT06325501 Comparator | Mar → Dec 2024 | leiomyoma | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT03463993 Background | Apr → Dec 2018 | — | University of Zimbabwe | Completed | No outcome recorded |
| Phase 3 | NCT02775773 Comparator | Jan → Dec 2018 | — | Azienda U.S.L. 1 di Massa e Carrara | Completed | No outcome recorded |
| Phase 3 | NCT03148574 Comparator | Jul 2017 → Sep 2019 | — | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT02888041 Comparator | Dec 2016 → Apr 2022 | cervix disorder, pregnancy disorder | University Hospital, Limoges | Terminated | No outcome recorded |
| Phase 3 | NCT02503319 Comparator | Jan 2016 | — | Azienda U.S.L. 1 di Massa e Carrara | Withdrawn | No outcome recorded |
| Phase 3 | NCT02702674 Comparator | Dec 2015 → Dec 2016 | — | Ain Shams Maternity Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02362945 Background | Oct 2015 → Jan 2017 | — | Yariv yogev | Unknown | No outcome recorded |
| Phase 3 | NCT02216383 Comparator | Feb 2015 → Aug 2018 | — | North Bristol NHS Trust | Completed | No outcome recorded |
| Phase 3 | NCT02304042 Comparator | Nov 2014 → Jul 2015 | — | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT02303418 Comparator | Nov 2014 → Nov 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT03138252 Comparator | Nov 2014 → Jul 2017 | cervix disorder | University Hospitals Cleveland Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT02306733 Comparator | Nov 2014 → Oct 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02304055 Comparator | May 2013 → Dec 2014 | obstetric disorder | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT02053922 Comparator | Dec 2012 → Aug 2013 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT01382732 Comparator | Jan 2012 → Dec 2015 | severe pre-eclampsia | Saint Thomas Hospital, Panama | Unknown | No outcome recorded |
| Phase 3 | NCT01412073 Comparator | Sep 2011 → Sep 2014 | — | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT01373359 Comparator | Mar 2007 → Jan 2008 | — | Jawaharlal Nehru Medical College | Completed | No outcome recorded |
| Phase 447 trials | ||||||
| Phase 4 | NCT07688512 Comparator | Aug 2026 → Aug 2028 expected | uterine disorder | Stony Brook University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07401524 Comparator | May 2026 → Mar 2028 expected | pregnancy disorder | Sheba Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT07119398 Comparator | Jul 2025 → Jul 2026 overdue | preterm premature rupture of the membranes | Eastern Virginia Medical School | Recruiting | No outcome recorded |
| Phase 4 | NCT05782816 Comparator | Apr 2023 → Dec 2024 | — | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
| Phase 4 | NCT05806307 Comparator | Mar → Oct 2023 | drug pseudoallergy, uterine corpus leiomyoma | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT05742854 Comparator | Mar → May 2023 | — | Ege University | Unknown | No outcome recorded |
| Phase 4 | NCT05664659 Comparator | Dec 2022 → Apr 2023 | — | Ain Shams Maternity Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05340205 Comparator | May → Dec 2022 | placenta praevia | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT05236985 Comparator | Mar 2022 → Dec 2024 | — | Stony Brook University | Unknown | No outcome recorded |
| Phase 4 | NCT05110482 Comparator | Nov 2021 → Jun 2023 | — | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT05079841 Comparator | Nov 2021 → Nov 2028 expected | — | Yale University | Recruiting | No outcome recorded |
| Phase 4 | NCT05215873 Comparator | Feb 2021 → Jan 2022 | preterm premature rupture of the membranes | Ain Shams Maternity Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04595812 Comparator | Nov 2020 → Aug 2022 | uterine corpus leiomyoma | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT04028765 Comparator | Aug 2019 → Dec 2022 | preterm premature rupture of the membranes | University of Pennsylvania | Completed | No outcome recorded |
| Phase 4 | NCT03892668 Comparator | Apr 2019 → Feb 2020 | uterine corpus leiomyoma | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03899961 Comparator | Apr 2019 → Mar 2022 | pregnancy disorder | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03676621 Comparator | Nov 2018 → Aug 2021 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT03693599 Comparator | Oct 2018 → Sep 2019 | — | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03680339 Comparator | Sep 2018 → Jan 2019 | — | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03651882 Comparator | Aug 2018 → Jan 2022 | — | University of Zurich | Completed | No outcome recorded |
| Phase 4 | NCT03755531 Comparator | Jan → Jun 2018 | — | Al-Kindy College of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT03246919 Comparator | Sep 2017 → Feb 2020 | pregnancy disorder | Loyola University | Terminated | No outcome recorded |
| Phase 4 | NCT02954068 Comparator | Dec 2016 → Sep 2017 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT02553226 Comparator | Apr 2016 → Jul 2020 | — | University of Aarhus | Completed | No outcome recorded |
| Phase 4 | NCT02723461 Comparator | Mar 2016 → Jan 2017 | — | Ain Shams Maternity Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02410655 Comparator | Nov 2015 → Jul 2017 | uterine disorder | NYU Langone Health | Withdrawn | No outcome recorded |
| Phase 4 | NCT02602301 Comparator | Nov 2015 → Mar 2016 | hyperbilirubinemia | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02528136 Comparator | Sep 2015 → Jan 2019 | pregnancy disorder | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02485444 Comparator | Jun 2015 → May 2016 | — | Ataturk University | Completed | No outcome recorded |
| Phase 4 | NCT02391636 Comparator | Feb 2015 → Sep 2016 | — | Ghamra Military Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02273115 Comparator | Oct 2014 → Sep 2016 | — | Christiana Care Health Services | Completed | No outcome recorded |
| Phase 4 | NCT02044549 Comparator | Jun 2014 → Dec 2015 | — | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT02101567 Comparator | May 2014 → Apr 2015 | anemia, hemorrhagic disease | Beni-Suef University | Completed | No outcome recorded |
| Phase 4 | NCT01614093 Comparator | Jun 2012 → Jan 2014 | schizophrenia | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 4 | NCT01549223 Comparator | Apr 2011 → Jan 2012 | hypotensive disorder, uterine disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00919802 Comparator | Jun 2010 → Sep 2015 | interstitial cystitis | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 4 | NCT01190163 Comparator | Jun 2010 → Jan 2012 | — | Ferring Pharmaceuticals | Terminated | No outcome recorded |
| Phase 4 | NCT00977769 Comparator | Nov 2009 → Aug 2011 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01216605 Comparator | Nov 2009 → Jan 2010 | — | University Hospital Freiburg | Completed | No outcome recorded |
| Phase 4 | NCT00784797 Comparator | Jan 2009 → Jun 2012 | — | Hadassah Medical Organization | Completed | No outcome recorded |
| Phase 4 | NCT00906347 Comparator | Dec 2008 → Jan 2011 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT00975416 Comparator | Nov 2008 → Apr 2013 | drug dependence | National Institute on Drug Abuse (NIDA) | Terminated | No outcome recorded |
| Phase 4 | NCT02488642 Background | May 2008 → Sep 2013 | uterine disorder | National Institute of Perinatology | Completed | No outcome recorded |
| Phase 4 | NCT00695331 Comparator | Feb → Dec 2008 | — | China Medical University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02150954 Comparator | Dec 2007 → Mar 2009 | — | Duke University | Completed | No outcome recorded |
| Phase 4 | NCT00777166 Comparator | Dec 2005 → Jul 2008 | hypotensive disorder, myocardial ischemia | Uppsala University | Completed | No outcome recorded |
| Phase 4 | NCT00200252 Comparator | Sep 2005 → Jul 2007 | — | Memorial University of Newfoundland | Completed | No outcome recorded |
| Phase not applicable89 trials | ||||||
| — | NCT07367672 Comparator | Dec 2025 → Feb 2026 overdue | — | University of Electronic Science and Technology of China | Recruiting | No outcome recorded |
| — | NCT07188207 Background | Oct 2025 → Oct 2026 expected | — | Assiut University | Not yet recruiting | No outcome recorded |
| — | NCT06930391 Comparator | Sep 2025 → Jun 2026 overdue | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT06333340 Comparator | Jan 2025 → Dec 2026 expected | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT07380529 Comparator | Oct 2024 → Aug 2025 | pregnancy disorder | Ankara Etlik City Hospital | Completed | No outcome recorded |
| — | NCT06560099 Comparator | Aug 2024 → Apr 2025 overdue | — | Ain Shams University | Not yet recruiting | No outcome recorded |
| — | NCT06413186 Background | May → Sep 2024 | placental abruption | Tarsus University | Unknown | No outcome recorded |
| — | NCT06285409 Comparator | Apr 2024 → Dec 2026 expected | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT06285396 Comparator | Mar 2024 → Dec 2026 expected | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT06889155 Comparator | Aug 2023 → May 2024 | — | Cairo University | Completed | No outcome recorded |
| — | NCT05920707 Comparator | Apr → Sep 2023 | — | University of Electronic Science and Technology of China | Unknown | No outcome recorded |
| — | NCT05532215 Background | Mar → Oct 2023 | — | OZORI EBIOGBO STANLEY | Unknown | No outcome recorded |
| — | NCT05511415 Comparator | Nov 2022 → Nov 2024 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT05532501 Comparator | Sep → Dec 2022 | — | University of Electronic Science and Technology of China | Unknown | No outcome recorded |
| — | NCT05341076 Background | Aug 2022 → Jul 2023 | dystocia | Assiut University | Unknown | No outcome recorded |
| — | NCT05479357 Comparator | Jul → Dec 2022 | pregnancy disorder | Sohag University | Unknown | No outcome recorded |
| — | NCT04303702 Comparator | Jul 2022 → Jun 2027 expected | — | Washington University School of Medicine | Recruiting | No outcome recorded |
| — | NCT05273632 Comparator | Mar → Sep 2022 | — | Egymedicalpedia | Completed | No outcome recorded |
| — | NCT05077540 Comparator | Nov 2021 → Oct 2023 | — | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT04906278 Background | Nov 2021 → Jun 2023 | — | Assiut University | Completed | No outcome recorded |
| — | NCT04902729 Comparator | Jul 2021 → Dec 2022 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT04996498 Comparator | Apr 2021 → Jul 2022 | leiomyoma | Ain Shams Maternity Hospital | Completed | No outcome recorded |
| — | NCT05251610 Comparator | Nov 2020 → Apr 2021 | — | Darlington-Peter Chibuzor Ugoji | Completed | No outcome recorded |
| — | NCT04201665 Comparator | Sep 2020 → Jan 2022 | — | University Medical Centre Ljubljana | Completed | No outcome recorded |
| — | NCT06343480 Comparator | Sep 2020 → Aug 2021 | — | Federal Teaching Hospital Abakaliki | Completed | No outcome recorded |
| — | NCT04518176 Background | Sep 2020 → Jun 2022 | — | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT04747015 Comparator | Jul 2020 → Dec 2021 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT04401839 Comparator | May 2020 → Aug 2021 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT04756661 Comparator | Jan → Dec 2020 | severe pre-eclampsia | Assiut University | Completed | No outcome recorded |
| — | NCT04143685 Comparator | Dec 2019 → Aug 2021 | preterm premature rupture of the membranes | sammour.rami | Unknown | No outcome recorded |
| — | NCT04017247 Comparator | Nov 2019 → Jun 2022 | — | Rambam Health Care Campus | Completed | No outcome recorded |
| — | NCT04025658 Comparator | Aug 2019 → Sep 2021 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT03957083 Comparator | Jun 2019 → Feb 2020 | obesity disorder | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT03870503 Comparator | Apr 2019 → Jun 2021 | — | Aswan University Hospital | Completed | No outcome recorded |
| — | NCT03852797 Comparator | Mar 2019 → Jan 2022 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT04134663 Comparator | Mar 2019 → Jun 2021 | — | University of Electronic Science and Technology of China | Completed | No outcome recorded |
| — | NCT03777878 Comparator | Jan 2019 → Mar 2021 | — | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT03710304 Comparator | Nov 2018 → Mar 2020 | — | Aswan University Hospital | Completed | No outcome recorded |
| — | NCT03578263 Comparator | Apr 2018 → Mar 2020 | — | Aswan University Hospital | Completed | No outcome recorded |
| — | NCT07436286 Comparator | Feb 2018 → Aug 2019 | — | Dangana Zakari Adeka | Completed | No outcome recorded |
| — | NCT03408054 Comparator | Jan → Apr 2018 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT03591679 Background | Dec 2017 → Nov 2018 | — | Assiut University | Completed | No outcome recorded |
| — | NCT03434444 Comparator | Sep 2017 → Aug 2022 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT03252496 Background | Aug 2017 → Jul 2021 | preeclampsia | Mansoura University | Completed | No outcome recorded |
| — | NCT03168698 Comparator | May 2017 → Dec 2020 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT02762669 Comparator | Aug 2016 → Dec 2023 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Terminated | No outcome recorded |
| — | NCT02647268 Comparator | Jan 2016 → Apr 2017 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT02618096 Comparator | Oct 2015 → Oct 2018 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02465164 Comparator | Jul 2015 → Jul 2016 | cervix disorder | Henry Ford Health System | Completed | No outcome recorded |
| — | NCT02910115 Background | May 2015 → Nov 2017 | dystocia, uterine disorder | Baylor Research Institute | Terminated | No outcome recorded |
| — | NCT01988649 Comparator | Apr → Jul 2015 | — | Northwestern University | Withdrawn | No outcome recorded |
| — | NCT02416583 Comparator | Apr 2015 → Jul 2018 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02393144 Background | Feb 2015 → Jan 2017 | pregnancy disorder | Ankara University | Unknown | No outcome recorded |
| — | NCT02063568 Comparator | Jan → Dec 2015 | — | Duke University | Withdrawn | No outcome recorded |
| — | NCT02861482 Background | Jan 2015 → Mar 2016 | — | Dongyu Wang | Completed | No outcome recorded |
| — | NCT02338089 Comparator | Jan → Jun 2015 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT03254628 Background | Nov 2014 → Dec 2016 | perinatal asphyxia | Jhpiego | Completed | No outcome recorded |
| — | NCT02274454 Comparator | Nov 2014 → Mar 2015 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT02314728 Comparator | Oct 2014 → May 2016 | pregnancy disorder, preterm premature rupture of the membranes, uterine disorder | Montefiore Medical Center | Completed | No outcome recorded |
| — | NCT02083809 Comparator | Oct 2014 → Feb 2018 | hemorrhagic disease | University of Hawaii | Completed | No outcome recorded |
| — | NCT02689596 Comparator | Oct 2014 → Oct 2015 | — | University Hospital Heidelberg | Completed | No outcome recorded |
| — | NCT02187874 Background | Jul 2014 → Jul 2017 | hemorrhagic stroke | Hospital Universitari Vall d'Hebron Research Institute | Unknown | No outcome recorded |
| — | NCT01914419 Comparator | Apr 2014 → Sep 2015 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT02121184 Comparator | Apr 2014 → Sep 2021 | pregnancy disorder | Northwestern University | Terminated | No outcome recorded |
| — | NCT02210598 Background | Mar 2014 → Jan 2018 | pregnancy disorder | University of Southern California | Unknown | No outcome recorded |
| — | NCT01973036 Background | Mar 2014 → Jul 2016 | preterm premature rupture of the membranes | Geisinger Clinic | Completed | No outcome recorded |
| — | NCT02046499 Comparator | Jan → Jun 2014 | — | University of Pretoria | Completed | No outcome recorded |
| — | NCT02985086 Comparator | Jul 2013 → Jul 2018 | — | Hospital de Santa Maria, Portugal | Unknown | No outcome recorded |
| — | NCT01869556 Comparator | Jun 2013 → Jul 2019 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT01827332 Comparator | Mar 2013 → Jun 2015 | cannabis dependence | Medical University of South Carolina | Completed | No outcome recorded |
| — | NCT01736852 Background | Nov 2012 → Dec 2018 | preterm premature rupture of the membranes | Cook Group Incorporated | Completed | No outcome recorded |
| — | NCT01600612 Comparator | Sep 2012 → Jun 2013 | — | Sohag University | Unknown | No outcome recorded |
| — | NCT01634854 Comparator | Jul 2012 → May 2014 | — | Vanderbilt University Medical Center | Completed | No outcome recorded |
| — | NCT00891150 Comparator | Jul 2012 → Feb 2013 | — | American University of Beirut Medical Center | Completed | No outcome recorded |
| — | NCT01608958 Comparator | May → Nov 2012 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT01719952 Comparator | Jan 2012 → Dec 2013 | pregnancy disorder | Universiti Kebangsaan Malaysia Medical Centre | Completed | No outcome recorded |
| — | NCT03335085 Comparator | Jul 2011 → Mar 2013 | — | Ruhr University of Bochum | Completed | No outcome recorded |
| — | NCT01335789 Comparator | Mar 2011 → Jul 2012 | cannabis dependence | Medical University of South Carolina | Completed | No outcome recorded |
| — | NCT01726478 Comparator | Feb → Apr 2011 | uterine disorder | Faculty of Medicine | Completed | No outcome recorded |
| — | NCT01954186 Comparator | Jan → Oct 2010 | — | Etlik Zubeyde Hanim Womens' Health and Teaching Hospital | Completed | No outcome recorded |
| — | NCT01689298 Comparator | Jan 2010 → Mar 2012 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT00984347 Comparator | Nov 2009 → Oct 2010 | — | Hadassah Medical Organization | Unknown | No outcome recorded |
| — | NCT01139801 Comparator | Sep 2009 → Mar 2010 | — | Aultman Health Foundation | Completed | No outcome recorded |
| — | NCT01677364 Comparator | Jul 2009 → Dec 2010 | heart disorder | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| — | NCT00957593 Comparator | Feb 2009 → Aug 2011 | — | Lehigh Valley Hospital | Completed | No outcome recorded |
| — | NCT02911272 Background | Apr 2008 → Apr 2013 | — | University of Benin | Completed | No outcome recorded |
| — | NCT00989027 Comparator | Jun 2007 → Aug 2013 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT00116350 Comparator | Jul 2005 → Jan 2008 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00120042 Comparator | Feb 2005 → Dec 2007 | placenta disorder | The University of Western Australia | Completed | No outcome recorded |
Evidence & citations 30 cited values
Every value below carries the sentence it was read from. 626 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxytocin | “This study will investigate if an intra-nasal nose spray of the drug oxytocin can decrease the amount of pressure needed from the automatic Continuous Positive Airway Pressure...” NCT03860233 ↗596“The role of oxytocin (OT) is already known in the regulation of satiety but some clinical studies demonstrated that OT participates also in the regulation of social behavior by...” NCT01038570 ↗ “This study will be carried out at Bangabandhu Sheikh Mujib Medical University (BSMMU) within six months after approval. This is a Randomized Control Trial which will compare...” NCT02396303 ↗ “one ampoule of syntometrine (Novartis, Basel, Switzerland), which consisted of 5 IU of oxytocin and 500 microgram of ergometrine diluted in 10 ml of Ringer's lactate solution...” NCT03693599 ↗ “In Oxytocin group (n=111), patients will receive 10 IU oxytocin (Syntocinon, Novartis, Basel, Switzerland) given as infusion in 500 ml lactated ringer/s solution at a rate of...” NCT06060327 ↗ “Syntocinon spray, 24 IU twice daily (A single dose will be delivered consisting of 6 intranasal insufflations (3 in each nostril) which is equivalent to a total of 24...” NCT02872467 ↗ “Intravenous administration of Actovegin, vitamins B1, B6, B12, C, oxytocin/dexamethasone, calcium gluconate, etc in 250 ml normal saline administered during approximately 2 hours” NCT03543917 ↗ “Intravenous oxytocin titration has a prime position as a choice agent for induction of labour following term PROM as it has been shown to be efficacious for such purpose.” NCT06343480 ↗ “Intravenous combination of 5 IU oxytocin and 0.2 mg ergometrine (300 women) after fetal extraction and before placental removal.” NCT02044549 ↗ “nasal oxytocin - 24 IU, 3 inhalations of 4IU to each nostril (45 sec waiting between the inhalations)” NCT01325168 ↗ “intranasal oxytocin (32 IE) or placebo will be self-administered by women prior to sexual intercourse” NCT02229721 ↗ “Participants will receive two doses of 24 IU intra-nasal oxytocin (Syntocinon) in a single session” NCT03225456 ↗ “The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)” NCT02336568 ↗ “Oxytocin is a commonly used drug for IOL, especially in a favorable cervix.” NCT06372522 ↗ “accepted treatment with oxytocin (10 units in 100ml NaCl 0.9% solution IV)” NCT02362945 ↗ “Oxytocin intranasal spray is manufactured as the Syntocinon Nasal Spray.” NCT01834261 ↗ “Each 0.1 ml nasal insulation delivers 4 IU of oxytocin.” NCT06036004 ↗ “Misoprostol, Dinoprostone, amniotomy, Oxytocin” NCT00385229 ↗ “Oxytocin nasal spray for 5 days, 24 IU per day” NCT03610919 ↗ “Intranasal administration of 24 IU Oxytocin” NCT02501837 ↗ “Synthetic oxytocin spray, 24 IU per spray.” NCT04505904 ↗ “Syntocinon ampoules (10 IU Oxytocin).” NCT02053922 ↗ “Syntocinon (=Oxytocin), then Placebo” NCT03497988 ↗ “single dose of synthetic oxytocin” NCT01216605 ↗ “TI-001 is intranasal oxytocin” NCT01839149 ↗ “Administer IV 10 IU oxytocin” NCT06413186 ↗ “oxytocin nasal spray” NCT05664516 ↗ “Intranasal Oxytocin” NCT02149823 ↗ “Drug: Oxytocin” NCT03010670 ↗ “Drug: Oxytocin” NCT01719952 ↗ “Oxytocin” NCT03096249 ↗ |
| Known as | d5OT | “A single, 1 International Unit (IU) bolus of deuterated oxytocin (d5OT) will be given to the subject” NCT05488457 ↗ |
| Known as | deuterated oxytocin | “A single, 1 International Unit (IU) bolus of deuterated oxytocin (d5OT) will be given to the subject” NCT05488457 ↗ |
| Known as | GR121619 | “A Single Centre, Single Blind Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of Oxytocin (GR121619) Administered Via an Inhaled Route in...” NCT02542813 ↗ |
| Known as | IN-OXT | “intranasal oxytocin (IN-OXT) vs. placebo” NCT02629991 ↗3“Intranasal Oxytocin (IN-OXT)” NCT06605300 ↗ “Intranasal Oxytocin (IN-OXT)” NCT04789148 ↗ “Intranasal Oxytocin (IN-OXT)” NCT07551882 ↗ |
| Known as | Inj. Linda | “The participants in experimental group will receive inj. (injection) oxytocin 10 IU (Inj. Linda 10 unit, Nuvista Pharmaceuticals Limited) intramuscular as trigger” NCT06725004 ↗ |
| Known as | Ocytocin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04046510 ↗ |
| Known as | OCYTOCINA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02007447 ↗ |
| Known as | OXT | “The treatment is aimed at enhancing maternal bonding, reducing postpartum depression (PPD) and anxiety in mothers at risk, and promoting child development. To this end, the...” NCT02505984 ↗20“The present study examines the impact of oxytocin (OXT) and Pivotal Response Treatment (PRT) on the development of language, social, and play skills in young children with...” NCT03370510 ↗ “Oxytocin (OXT), a neuropeptide produced in the hypothalamus, is a key modulator of complex socioaffective responses including affiliation, social approach and attachment,...” NCT03428906 ↗ “Oxytocin (OXT), a neuropeptide produced in the hypothalamus, is a key modulator of complex socioaffective responses including affiliation, social approach and attachment,...” NCT03891095 ↗ “Oxytocin (OXT), a neuropeptide produced in the hypothalamus, is a key modulator of complex socioaffective responses including affiliation, social approach and attachment,...” NCT03597893 ↗ “Oxytocin (OXT), a neuropeptide closely associated with AVP in terms of anatomical location and function, is known to play a critical role in social, emotional, and behavioral...” NCT06808516 ↗ “Endogenous oxytocin (OXT) has been a focus of prior psychiatric research due to its role in pro-social behavior, and modulation of response to social/emotional stimuli.” NCT03863288 ↗ “Emerging evidence suggests that the neuropeptide oxytocin (OXT) may be a blood-based biomarker of social functioning and a possible treatment for ASD.” PMID 28696286 ↗ Jul 2017 “The neuropeptide oxytocin (OXT) may facilitate social interactions either by increasing their rewarding experience or by attenuating anxiety” PMID 30086408 ↗ Aug 2018 “Oxytocin (OXT), a neuropeptide involved in social cognition, is a potential therapeutic agent for alleviating social dysfunction.” PMID 33587397 ↗ Mar 2021 “The hypothalamic peptide oxytocin (OXT) has anxiolytic effects both in healthy participants and patients with anxiety disorders” NCT03829839 ↗ “One promising candidate to reduce stress and improve quality of life is the endogenous neuropeptide oxytocin (OXT).” NCT06364228 ↗ “The neuropeptide oxytocin (OXT) exerts anxiolytic and anti-stress effects in visual and auditory modalities” NCT03265899 ↗ “The neuropeptide oxytocin (OXT) has been shown to modulate several aspects of human social cognition.” NCT02183948 ↗ “ASD is also characterized by low levels of oxytocin (OXT), a peptide hormone with prosocial effects.” NCT05754073 ↗ “hypothalamic neuropeptide Oxytocin (OXT) may modulate attention allocation and regulation” NCT03486925 ↗ “the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making” NCT04890470 ↗ “Oxytocin (OXT), as a neuropeptide, plays a role in emotional and social behaviors.” PMID 32082606 ↗ Feb 2020 “the neuropeptide oxytocin (OXT) influences self-processing” NCT02963194 ↗ “Oxytocin (OXT) is an important prosocial peptide” NCT01699997 ↗ “the neuropeptide oxytocin (OXT)” NCT04330677 ↗ |
| Known as | OXY | “One potential compound is oxytocin (OXY), which proved beneficial effects on alcohol craving and stress reactivity in preliminary clinical studies and synergism with NTX effects.” PMID 35410938 ↗ Apr 2022 |
| Known as | OXYTIP | “Oxytocin (OXYTIP; manufactured by IPDIC, Rasht, Iran), 5 IU and hCG (Choriomon; manufactured by IBSA Institute Biochimique SA, CH-6903 Lugano), 5000 IU were also administrated...” NCT00844350 ↗ |
| Known as | Oxytocin (Syntocinon) | “Oxytocin (Syntocinon)” NCT02205034 ↗ |
| Known as | Oxytocin Grindeks | “Oxytocin Grindeks 10 IU/ml- solution for injection” NCT06990217 ↗ |
| Known as | Oxytocin: Syntocinon Nasal Spray | “Oxytocin: Syntocinon Nasal Spray” NCT01566539 ↗ |
| Known as | Oxytocin: Syntocinon-Spray, Novartis | “Oxytocin: Syntocinon-Spray, Novartis” NCT01607970 ↗2“Oxytocin: Syntocinon-Spray, Novartis” NCT01701180 ↗ “Oxytocin: Syntocinon-Spray, Novartis” NCT01606462 ↗ |
| Known as | Pitocin | “they then received a single 40 IU dose of Pitocin (oxytocin, USP; concentration = 10 IU/1 mL; PAR Pharmaceuticals, NY, USA) during the second experimental session, which...” NCT02595749 ↗14“A single 40 IU dose of Pitocin (oxytocin, USP; concentration = 10 IU/1 mL; PAR Pharmaceuticals, NY, USA) will be self-administered to each participant.” NCT03819231 ↗ “Prior literature has examined the use of Pitocin (Oxytocin), vaginal and oral misoprostol, and dinoprost with mixed results.” NCT04028765 ↗ “The protocol for oxytocin infusion is 4 units of Pitocin in 10 cc 0.9% NaCl” NCT02684305 ↗ “up titration of Pitocin if contractions are inadequate” NCT06702670 ↗ “10 IU oxytocin (Pitocin) for intramuscular injection” NCT03935399 ↗ “Intramuscular injection of Oxytocin (Pitocin®)” NCT04427709 ↗ “Oxytocin (also: syntocinon, pitocin)” NCT00813436 ↗ “oxytocin (Pitocin)” NCT00914953 ↗ |
| Known as | RVG 03716 | “Syntocinon nasal spray (40 IU/ml; oxytocin, product code RVG 03716)” NCT04443647 ↗ |
| Known as | Synpitan forte | “Group II: Oxytocin(Synpitan forte®; Deva Pharma, Istanbul, Turkey)” NCT05467462 ↗1“Group I: Oxytocin(Synpitan forte®; Deva Pharma, Istanbul, Turkey)” NCT05083910 ↗ |
| Known as | synthetic oxytocin | “Syntocinon (synthetic oxytocin)” NCT02090829 ↗ |
| Known as | syntocinon | “An equal volume of normal saline syringe in a double blinded manner will be intravenously administered to the OXYtocin group 30 min before surgery and will be followed by one...” NCT03892668 ↗45“Patients will self-administer a 2-week course of 24-IU intranasal oxytocin \[4-IU per puff (12-IU delivered to each nostril); Syntocinon, Novartis, Switzerland\], twice per day...” NCT04903002 ↗ “Syntocinon spray, 24 IU twice daily (A single dose will be delivered consisting of 6 intranasal insufflations (3 in each nostril) which is equivalent to a total of 24...” NCT02872467 ↗ “In Oxytocin group (n=111), patients will receive 10 IU oxytocin (Syntocinon, Novartis, Basel, Switzerland) given as infusion in 500 ml lactated ringer/s solution at a rate of...” NCT06060327 ↗ “Other names are Pitocin, syntocinon given as an intravenous bolus over 30 seconds by the anaesthetist following clamping of the umbilical cord only in patient that has been...” NCT01719952 ↗ “OBJECTIVE: To determine the safety and tolerability of 3 doses of intranasal oxytocin (Syntocinon; Novartis, Bern, Switzerland) administered to patients with frontotemporal...” PMID 25503617 ↗ Dec 2014 “10 IU of oxytocin (Syntocinon, Novartis, Basel, Switzerland) were diluted in 500 mL of normal saline and administered through intravenous infusion over 30 minutes.” NCT06889155 ↗ “Patients will receive 5 units of oxytocin ( Syntocinon ®) as a 250 ml 0.9% NaCl infusion at admission to high dependency obstetric unit after cesarean section.” NCT04201665 ↗ “Participants will self-administer a single dose of 24 IU oxytocin (Syntocinon, Novartis; three puffs per nostril, each with 4 IU oxytocin, 6 puffs total).” NCT02443727 ↗ “participants will self-administer 24 IU oxytocin (Syntocinon, Novartis Pharmaceuticals). 5 puffs per nostril (1 puff = 2.4 IU oxytocin).” NCT02393443 ↗ “Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland).” NCT02303418 ↗ “Immediate intraumbilical vein injection of Oxytocin (Syntocinon®) 20 units diluted in 20 ml of 0.9% saline solution” NCT03395730 ↗ “oxytocin 40 I.U. intramyometrially (Syntocinon, Ampule 10 I.U. in 1 ml, Oxytocin; NOVARTIS, Basel, Switzerland)” NCT05806307 ↗ “20 unit of oxytocin infusion in 500 ml lactated ringer's solution 125 ml/h (Syntocinon, Novartis, Switzerland)” NCT05077540 ↗ “Syntocinon nasal spray (40 IU/ml; oxytocin, product code RVG 03716) will be used for intranasal administration” NCT03096249 ↗ “The study drug is oxytocin in intra-nasal administration, Syntocinon®, reconditioned as a placebo-like spray.” NCT03114371 ↗ “FMRI measurement and blood examinations after 26 IU Oxytocin (Syntocinon)or placebo on two consecutive days” NCT01712464 ↗ “the preparation of intranasal OT is manufactured by Novartis and sold under the trade name: Syntocinon.” NCT00884897 ↗ “Participants will receive two doses of 24 IU intra-nasal oxytocin (Syntocinon) in a single session” NCT03225456 ↗ “100 women with atonic PPH will receive oxytocin 10 IU (Syntocinon®, Novartis, Switzerland).” NCT02306733 ↗ “participants will self-administer 24 IU oxytocin (Syntocinon, Novartis Pharmaceuticals).” NCT02393456 ↗ “following 26 IU Oxytocin (Syntocinon) on day 1 and following placebo on day 14” NCT02350946 ↗ “group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland).” NCT02304055 ↗ “Group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland)” NCT02304042 ↗ “Syntocinon nasal spray (40 IU/ml; oxytocin, product code RVG 03716)” NCT04443647 ↗ “Syntocinon (synthetic oxytocin) will be used in this protocol.” NCT03197662 ↗ “followed by Oxytocin 5U.I/ml (Syntocinon®) (if necessary)” NCT02888041 ↗ “Intranasal oxytocin (Syntocinon; Novartis, Switzerland)” NCT02888574 ↗ “Syntocinon® (synthetic oxytocin) to induce labour” NCT02553226 ↗ “Oxytocin (also: syntocinon, pitocin)” NCT00813436 ↗ “Syntocinon (Oxytocin) nasal spray” NCT01594775 ↗ “Syntocinon (Oxytocin)” NCT02940574 ↗ “Syntocinon” NCT02985749 ↗ |
| Known as | Syntocinon nasal spray | “A single dose of 80 I.U. oxytocin in aerosol form (Syntocinon® nasal spray) is administered via 20 puffs 2 times per week intranasally.” NCT06881810 ↗4“Single-dose intranasal oxytocin (24 IU; Syntocinon® nasal spray, Victoria Pharmacy, Zürich, Switzerland)” NCT03136263 ↗ “Subjects will use the Syntocinon® Nasal Spray (oxytocin) twice daily for 8 weeks” NCT01308749 ↗ “Oxytocin intranasal spray is manufactured as the Syntocinon Nasal Spray.” NCT01834261 ↗ |
| Known as | Syntocinon-spray | “Subjects receiving an intranasal spray of OXT (24 IU or 40.32 mg; Syntocinon-spray; Novartis, Switzerland)” NCT03891095 ↗1“Oxytocin: Syntocinon-Spray, Novartis” NCT02156661 ↗ |
| Known as | TI-001 | “TI-001 is intranasal oxytocin” NCT01839149 ↗ |
| Known as | TNX-1900 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05679908 ↗ |
| Known as | TTA-121 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03466671 ↗ |
| Known as | Vagitocin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01975129 ↗ |
| Action | Inhibit | “Oxytocin administered peripherally inhibits dopamine transmission” NCT00506909 ↗ |
| Modality | Peptide | “Oxytocin is a neurohypophyseal peptide” NCT00506909 ↗ |
| Route | Intravenous | “40 IU Oxytocin IV” NCT00116350 ↗ |
| Target | OXTR | “Oxytocin acts directly on the myometrium through the oxytocin receptor(OXTR) and stimulates contractions.” NCT04595812 ↗ |